CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva

Journal of the Society for Gynecologic Investigation

Volumn 7, Issue 1, 2000, Pages 70-75

  Rodríguez Rodríguez, Lorna ^a,b   Sancho Torres, Inés ^a   Gibbon, Darlene G ^a,b   Miller Watelet, Luc F ^a   Mesonero, Clara ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

CD44; Metastasis molecular markers; Vulvar carcinoma

Indexed keywords

CELL SURFACE PROTEIN; HERMES ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; RNA SPLICING; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; REGISTRIES; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS;

EID: 0342546439     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(99)00045-3     Document Type: Article

References (21)

1. Bracke M.E., Charlier C., Bruyneel E.A. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res. 54:1994;4607.
2. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis An imbalance of positive and negative regulation . Cell. 64:1991;327.
3. Underhill C.B., Chi-Rosso G., Toole B.P. Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40-transformed 3T3 cells. J Biol Chem. 258:1983;8086-8091.
4. Naor D., Sionov R.V., Ish-Shalom D. CD44 Structure, function and association with the malignant process . Vande Woude G.F., Klein G. Advances in cancer research. 71:1997;241-318 Academic Press, San Diego.
5. Soukka T., Salmi M., Joensuu H., et al. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res. 57:1997;2281-2289.
6. Teder P., Bergh J., Heldin P. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not other lung carcinoma cell lines. Cancer Res. 55:1995;3908-3914.
7. Friedrichs K., Folker F., Björn-Wieland L., et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res. 55:1995;5424-5433.
8. Rodriguez C., Monges G., Rouanet P., et al. CD44 expression patterns in breast and colon tumors A PCR-based study of splice variants . Int J Cancer. 64:1995;347-354.
9. Li H., Hamou M.F., de Tribolet N., et al. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res. 53:1993;5345-5349.
10. Tempfer C., Gitsch G., Haeusler G., et al. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Cancer. 78:1996;273-277.
11. Tempfer C., Gitsch G., Hanzal E., et al. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma. Anticancer Res. 16:1996;2029-2032.
12. Ambros R.A., Kallakury B.V., Malfetano J.H., et al. Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma Correlation with prominent fibromyxoid stromal response . Int J Gynecol Pathol. 15:1996;320-325.
13. Rodríguez-Rodríguez L., Sancho-Torres I., Mesonero C., et al. CD44 splice variant expression in clear cell carcinoma of the ovary. J Gynecol Oncol. 71:1998;223-229.
14. Sturgeon S.R., Brinton L.A., Devesa S.S., et al. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol. 166:1992;1482.
15. Dall P., Heider K.H., Hekele A., et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res. 54:1994;3337-3341.
16. Kainz C., Kohlberger P., Sliutz G., et al. Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol. 57:1995;383-387.
17. Dellas A., Schultheiss E., Almendral A.C., et al. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia. Gynecol Oncol. 62:1996;218-225.
18. Lagorce-Pages C., Paraf F., Dubois J., et al. Expression of CD44 in premalignant and malignant barrett's oesophagus. Histopathology. 32:1998;7-14.
19. Ingle R., Jennings T., Goodman M., et al. CD44 expression in sinonalsal inverted papillomas and associated squamous cell carcinoma. ACJP. 109:1998;309-314.
20. Steelentag W., Gunthert U., Saremaslani P., et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer. 69:1996;218-224.
21. Seiter S., Tilgen W., Herrmann K., et al. Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Arch. 428:1996;141-149.